All In MedTech

Device Trial Radar · NCT07478172

Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease

Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults withNeuromuscular Disease

Last checked: Nov 20, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

50

Planned (sponsor's estimate)

Start

Mar 10, 2026

Primary completion

Dec 31, 2030

Study completion Jan 7, 2031

Sponsor

Lead sponsor
University of Missouri-ColumbiaAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Mar 17, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This single-arm pilot study evaluates the effects of whole-body electrical muscle stimulation (WB-EMS) exercise on neuromuscular and physical function in adults with neuromuscular disease (NMD). Due to motor unit impairments, NMD patients often cannot tolerate traditional exercise. WB-EMS bypasses voluntary activation limits by directly stimulating muscle contractions. Up to 50 adults with conditions like ALS, SMA, and MG will undergo 20-minute supervised WB-EMS sessions (1-2 times weekly for 4-8 weeks) using the Katalyst system. Outcomes include neural excitability (TMS), motor unit behavior (EMG, NCS), functional tests (walk, balance, strength), and patient-reported fatigue, pain, and quality of life. Strict safety monitoring and exclusion criteria are in place. This study will provide preliminary data on WB-EMS as a potential exercise modality for NMD.

Conditions

  • Neuromuscular Diseases (NMD)
  • Amyotrophic Lateral Sclerosis
  • Myasthenia Gravis
  • Lambert-eaton Myasthenic Syndrome
  • Primary Lateral Sclerosis
  • Spinal Muscular Atrophy
  • Charcot Marie Tooth Disease (CMT)
  • Fascioscapulohumeral Muscular Dystrophy
  • Inclusion Body Myositis
  • Mitochondrial Myopathy
  • Nemaline Myopathy
  • Centronuclear Myopathy
  • Postpolio Syndrome
  • Pompe Disease (Late-onset)
  • Chronic Inflammatory Demyelinating Polyneuropathy
  • Hereditary Spastic Paraplegia
  • Postural Orthostatic Tachycardia Syndrome (POTS)
  • Progressive Muscular Atrophy

Interventions

  • Whole-body Electrical Muscle Stimulation ExerciseDevice

    Katalyst is a fitness device that delivers Whole-body Electrical Muscle Stimulation in conjunction with exercise programs (WB-EMS Exercise). After donning a base layer consisting of fitted shorts and shirt, a vest, shorts, and arm straps with integrated electrodes mapped to major muscle groups (biceps, triceps, pectorals, abdominals, periscapular musculature, paraspinal musculature, gluteus musculature, quadriceps, and hamstrings) are donned. The suit connects to an impulse pack that communicates with the Katalyst iPad App to deliver the programmed stimulation to the participant. Within the Katalyst App, there are leveled exercise programs where low levels (i.e. Level 1 and 2) are simple movements and higher levels (i.e. Levels 3, 4, and 5) have more complex and dynamic movements. There is complete user control of the stimulation level of each individual muscle group to tailor to participant responses and tolerance.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean change from baseline in motor unit firing rates using decomposition electromyography (dEMG)Time frame: Measured 4-7 days prior to the start of intervention (Week 1) and 4-7 days after 4 weeks of intervention (Week 6 and Week 11).

3 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • NextGen Precision Health Building, Clinical and Translational Science Unit

    Columbia, Missouri

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.